Cardiovascular disease continues to be the leading cause of death worldwide. To save lives, constantly improving diagnostic and risk assessments is ...

A review of 3 common risk assessment tools for pulmonary arterial hypertension (PAH) found they successfully predict survival for up to 5 years after initial diagnosis. The 3 assessments reviewed were ...

In the current issue of Cardiovascular Innovations and Applications (Special Issue on Women's Cardiovascular Health, Volume 3, Number 4, 2019, Guest Editor Gladys P ...

Diagnostic delays in hypertension lead to lower treatment rates and increased cardiovascular risk, with prescription rates decreasing as delays lengthen. Delayed diagnoses correlate with a higher risk ...